Aims and Scope

Cardiovascular Innovations and Applications (CVIA) is a peer-reviewed, platinum open-access journal publishing focused articles and original clinical research that explore novel developments in cardiovascular disease, effective control and rehabilitation in cardiovascular disease, and promote cardiovascular innovations and applications for the betterment of public health globally. The journal publishes basic research that has clinical applicability in order to promote timely communication of the latest insights relating to coronary artery disease, heart failure, hypertension, cardiac arrhythmia, prevention of cardiovascular disease with a heavy emphasis on risk factor modification.

Cardiovascular Innovations and Applications (CVIA) also welcomes commentaries, case studies and reports, letters to the editor, methodology papers related to clinical trials, education and training articles, techniques and videos. CVIA does not impose any article processing charges (APC) or submission charges.

Information for Contributors

The journal of Cardiovascular Innovations and Applications (CVIA) encourages its contributors and reviewers to adopt the standards of the International Committee of Medical Journal Editors .  The Journal will not consider papers that have been accepted for publication or published elsewhere. Our FULL requirements for submission, including our conflicts of interest disclosure, trial registration and ethics policies are described in detail in the Instructions for Authors.

Submission Process

Submissions to Cardiovascular Innovations and Applications (CVIA) are made using ScholarOne Manuscripts, the online submission and peer review system.

Registration and access is available at https://mc04.manuscriptcentral.com/cvia-journal. Full information and guidance on using ScholarOne Manuscripts is available here http://mchelp.manuscriptcentral.com/gethelpnow/.

In case you do not receive the confirmation email after a week, contact the editorial office to track your manuscript by emailing the editorial office.

Click here for more information on the Submission Process

Pre-Submission Guide and Queries

If you want an informal opinion before you submit, you can send your abstract and brief note explaining why your manuscript is suitable for our journal by email to the editorial office.

Disclosures

Each author must disclose all financial relationship related to the subject of the paper.  This should include equity ownership, profit-sharing agreements, royalties, patents, and grants. Income from pharmaceutical companies should be specified by type, e.g. speaker’s honoraria, expenses, grants, etc. Authors do not need to report the sums concerned. If none, state “none”.